TransMedics Group Files 8-K on Financial Condition
Ticker: TMDX · Form: 8-K · Filed: Feb 26, 2024 · CIK: 1756262
| Field | Detail |
|---|---|
| Company | Transmedics Group, Inc. (TMDX) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, 8-K
TL;DR
**TransMedics Group just dropped an 8-K on its financials, so keep an eye out for the details!**
AI Summary
TransMedics Group, Inc. filed an 8-K on February 26, 2024, to report on its results of operations and financial condition. The filing indicates that the company, based in Andover, Massachusetts, with CIK 0001756262, is providing an update on its financial performance. This report is filed under the Securities Exchange Act of 1934, with a commission file number of 001-38891.
Why It Matters
This filing provides investors with an update on TransMedics Group's financial health and operational performance, which can influence investment decisions and market perception.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial condition and results of operations, not indicating any immediate adverse events.
Key Players & Entities
- TransMedics Group, Inc. (company) — Registrant
- February 26, 2024 (date) — Date of earliest event reported
- 001-38891 (other) — Commission File Number
- Massachusetts (other) — State of Incorporation
- 200 Minuteman Road, Andover, Massachusetts, 01810 (other) — Principal Executive Offices Address
FAQ
What is the purpose of this 8-K filing by TransMedics Group, Inc.?
The 8-K filing by TransMedics Group, Inc. is to report on the company's Results of Operations and Financial Condition, as well as Financial Statements and Exhibits, as of February 26, 2024.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 26, 2024.
What is the Commission File Number for TransMedics Group, Inc.?
The Commission File Number for TransMedics Group, Inc. is 001-38891.
Where are TransMedics Group, Inc.'s principal executive offices located?
TransMedics Group, Inc.'s principal executive offices are located at 200 Minuteman Road, Andover, Massachusetts, 01810.
Under which Act is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 516 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-02-26 16:19:57
Filing Documents
- tmdx-20240226.htm (8-K) — 38KB
- tmdx-ex99_1.htm (EX-99.1) — 269KB
- 0000950170-24-020175.txt ( ) — 428KB
- tmdx-20240226.xsd (EX-101.SCH) — 23KB
- tmdx-20240226_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 26, 2024, TransMedics Group, Inc. (the "Company") issued a press release announcing the Company's financial results for the quarter and year ended December 31, 2023. A copy of this press release is furnished as Exhibit 99.1 and is incorporated herein by reference. The information in this Form 8-K (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing by the Company, under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by TransMedics Group, Inc. on February 26, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRANSMEDICS GROUP, INC. Date: February 26, 2024 By: /s/ Stephen Gordon Name: Stephen Gordon Title: Chief Financial Officer and Treasurer